Search Prime Contracts

75F40118D10022-75F40120F19003

Delivery Order

Overview

Government Description
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR THEIR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: DATA, TOOLS AND INFRASTRUCTURE FOR SURVEILLANCE OF BIOLOGICS
Place of Performance
Bethesda, MD 20817 United States
Pricing
Time And Materials
Set Aside
None
Extent Competed
Full And Open Competition
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 09/28/23 to 03/28/24 and the Potential Award value has decreased 12% from $15,042,937 to $13,239,710.
Predecessor This appears to be a continuation of a prior contract 75F40118D10053-75F40119F19002.
Subcontracting Plan This Delivery Order has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
International Business Machines Corporation was awarded Delivery Order 75F40120F19003 (75F401-20-F-19003) worth up to $13,239,710 by the FDA Office of Acquisition and Grant Services in September 2020. The contract has a duration of 3 years 6 months and was awarded through solicitation Biologics Effectiveness and Safety (BEST) Initiative: Data, Tools and Infrastructure for Surveillance of Biologics full & open with NAICS 518210 and PSC B537 via subject to multiple award fair opportunity acquisition procedures with 1 bid received. This contract was awarded through vehicle Biologics Effectiveness and Safety (BEST) Initiative - Data, Tools, and Infrastructure for Surveillance of Biologics.

Status
(Complete)

Last Modified 12/20/23
Period of Performance
9/29/20
Start Date
3/28/24
Current End Date
3/28/24
Potential End Date
100% Complete

Obligations
$13.2M
Total Obligated
$13.2M
Current Award
$13.2M
Potential Award
100% Funded

Award Hierarchy

Indefinite Delivery Contract

75F40118D10022

Delivery Order

75F40118D10022-75F40120F19003

Subcontracts

-

Activity Timeline

Interactive chart of timeline of amendments to 75F40118D10022-75F40120F19003

Labor Services Billing

Annual labor billing rates and FTE reported for 75F40118D10022-75F40120F19003

Subcontract Awards

Disclosed subcontracts for 75F40118D10022-75F40120F19003

Opportunity Lifecycle

Procurement history for 75F40118D10022-75F40120F19003

Transaction History

Modifications to 75F40118D10022-75F40120F19003

People

Suggested agency contacts for 75F40118D10022-75F40120F19003

Competition

Number of Bidders
1
Solicitation Procedures
Subject To Multiple Award Fair Opportunity
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
VV9KH3L99VE3
Awardee CAGE
3BXY7
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhslillianlamb
Last Modified By
hhsian_weiss
Approved By
hhsian_weiss

Legislative

Legislative Mandates
Labor Standards
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Representative
Jamie Raskin

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) Consumer and occupational health and safety Other services from non-Federal sources (25.2) $4,044,816 52%
Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) Consumer and occupational health and safety Other goods and services from Federal sources (25.3) $1,783,494 23%
FDA Innovation, CURES Act, Food and Drug Administration, Health and Human Services (075-5629) Consumer and occupational health and safety Other goods and services from Federal sources (25.3) $1,000,000 13%
FDA Innovation, CURES Act, Food and Drug Administration, Health and Human Services (075-5629) Consumer and occupational health and safety Other services from non-Federal sources (25.2) $967,025 12%
Modified: 12/20/23